Zydus Lifesciences Q2 Net Profit up by 53% Y-o-Y

Nov 07, 2023

Ahmedabad (Gujarat) [India], November 7: Zydus Lifesciences Ltd. announced its unaudited consolidated financial results for the quarter and half year ended September 30th, 2023.

Zydus gets USFDA's final nod to market antifungal Micafungin for injection

Oct 26, 2022

Zydus Lifesciences has received approval from US Food and Drug Administration to market Micafungin.

DCGI grants EUA to ZycovD COVID vaccine for two-dose regimen for children above 12

Apr 26, 2022

Ahmedabad (Gujarat) [India], April 26 : The Drugs Controller General of India (DCGI) on Tuesday granted Emergency Use Authorisation (EUA) to Zydus Cadila vaccine...

Zydus Reports 97 per cent Growth in Net Profit in FY24

May 18, 2024

Ahmedabad (Gujarat) [India], May 18: Zydus Lifesciences Limited announces Q4 and FY24 financial performance. Summary:

Zydus receives final approval from USFDA to market Colestipol Hydrochloride tablets

Mar 14, 2022

Ahmedabad (Gujarat) [India], March 15 : Zydus Lifesciences Ltd. has received final approval from the United States Food and Drug Administration (USFDA) to market...

Zydus Lifesciences gets DCGI approval for Oxemia drug

Mar 07, 2022

Ahmedabad (Gujarat) [India], March 7 : Zydus Lifesciences on Monday said it has received approval from the Drug Controller General of India (DCGI) for...